Self-assembled extracellular matrix-lipid nanoparticle composite for site-specific siRNA delivery to improve cardiac repair post-myocardial infarction
Materials Today Bio · 2025-10 · 34 · 102205
DOI: 10.1016/j.mtbio.2025.102205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2025-10. Verfasst von Xinming Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science Fund for Distinguished Young Scholars, Shanghai Jiao Tong University, Key Technologies Research and Development Program.
Abstract (Originalsprache)
Cardiovascular disease remains a leading cause of mortality, highlighting the critical need for novel therapeutic strategies. RNA-based therapeutics, including siRNA and mRNA, offer promising approaches for cardiac diseases, yet their clinical application is limited by low heart specificity and suboptimal delivery methods. Lipid nanoparticles (LNPs) are widely used for RNA delivery but often accumulate in non-cardiac tissues, reducing their effectiveness. To address this, an extracellular matrix (ECM)-LNP composite is developed for targeted RNA delivery to the myocardium. The LNPs are conjugated to the ECM scaffold to enhance RNA retention. In vivo experiments demonstrate effective mRNA delivery and expression within the heart, with preferential targeting towards immune cells. Epidermal growth factor receptor (EGFR), a key regulator of cell proliferation and inflammation, is found to affect macrophage polarization in this study. The therapeutic potential of EGFR siRNA delivered via ECM-LNP composite is further explored in a mouse model of myocardial infarction (MI). Results indicate that ECM-siEGFR@LNP reduces cardiac fibrosis and promotes M2 macrophage polarization. This effect is associated with down-regulation of the EGFR-AKT signaling pathway. In conclusion, this study presents an injectable platform for heart-specific RNA delivery and sheds light on the role of EGFR signaling in the cardiac repair process.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Förderung
- National Science Fund for Distinguished Young Scholars
- Shanghai Jiao Tong University
- Key Technologies Research and Development Program
- Shanghai Education Development Foundation
- Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital
- Shanghai Municipal Education Commission
- Shandong Jiaotong University
- National Key Research and Development Program of China
Zitieren
APA
Wang, X., Zhong, Y., Qian, B., Huang, S., Long, Q., Zhang, H., Zhao, Q., & Ye, X. (2025). Self-assembled extracellular matrix-lipid nanoparticle composite for site-specific siRNA delivery to improve cardiac repair post-myocardial infarction. Materials Today Bio, 34, 102205. https://doi.org/10.1016/j.mtbio.2025.102205
Vancouver
Wang X, Zhong Y, Qian B, Huang S, Long Q, Zhang H, et al. Self-assembled extracellular matrix-lipid nanoparticle composite for site-specific siRNA delivery to improve cardiac repair post-myocardial infarction. Materials Today Bio. 2025;34:102205. doi:10.1016/j.mtbio.2025.102205
BibTeX
@article{Wang2025,
author = {Wang, Xinming and Zhong, Yiming and Qian, Bei and Huang, Shixing and Long, Qiang and Zhang, Haonan and Zhao, Qiang and Ye, Xiaofeng},
title = {Self-assembled extracellular matrix-lipid nanoparticle composite for site-specific siRNA delivery to improve cardiac repair post-myocardial infarction},
journal = {Materials Today Bio},
year = {2025},
volume = {34},
pages = {102205},
doi = {10.1016/j.mtbio.2025.102205}
}
EUVIMED